Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$2.25 - $3.03 $112,050 - $150,894
-49,800 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$3.82 - $5.32 $190,236 - $264,936
49,800 New
49,800 $250,000

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $67.6M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.